
Influenza A (strain A/X-31 H3N2) Hemagglutinin 114-121, YPYDVPDYA
Description
About Influenza A (strain A/X-31 H3N2) Hemagglutinin 114-121, YPYDVPDYA
The Influenza A (strain A/X-31 H3N2) Hemagglutinin Peptide (IEDB: 75441) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Hemagglutinin Peptide, H-YPYDVPDYA-OH (Uniprot: P03438 aa: 114-121) from JPT is produced under strict quality control and quality management.
Influenza A (strain A/X-31 H3N2) Hemagglutinin 114-121, YPYDVPDYA - Specifications
- Peptide sequence: H-YPYDVPDYA-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- CAS: 92000-76-5
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Influenza
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Influenza A (strain A/X-31 H3N2) Hemagglutinin 114-121, YPYDVPDYA
References:
Read References with JPT’s Antigen Peptides
Influenza A (strain A/X-31 H3N2) Hemagglutinin 114-121, YPYDVPDYA has been described in:
Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity., J Virol, 2006 (PMID: 16699033)
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8<sup>+</sup> and CD4<sup>+</sup> T-cell responses with multiple specificities including a novel DR7-restricted epitope., Oncoimmunology, 2016 (PMID: 27853637)
Documentation
Documentation for Influenza A (strain A/X-31 H3N2) Hemagglutinin 114-121, YPYDVPDYA
Properties
Properties of Influenza A (strain A/X-31 H3N2) Hemagglutinin 114-121, YPYDVPDYA
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Influenza |
Layout: | Freeze-dried in glass vial |
Organism: | Influenza A |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Influenza A (strain A/X-31 H3N2) Hemagglutinin 114-121, YPYDVPDYA
Information | Values |
---|---|
Sequence: | H-YPYDVPDYA-OH |
Specifications: | 9mer peptide as TFA salt |